Recital 258, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

The majority of respondents expressing a view were confident that the

commitments included sufficient production assets, know-how, intellectual property and staff to allow a purchaser to develop the lactase entry and pipeline products so that they can be successfully brought to market.

362 The Commission notes that this should happen within the next [time period] following the transfer of the Divestment Business to a suitable purchaser.